• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
APTX

APTX

Aptinyx Inc.

NASDAQHealthcareBiotechnologyUS

USD0.10

+0.00 (+3.17%)

Company Profile

CEO

Craig R. Jalbert CIRA

IPO Date

2018-06-21

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.09

Prev. Close

$0.09

Day Low

$0.09

Day High

$0.10

52W Low

$0.01

52W High

$0.72

Volume

0.23M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

21.8%

Avg Negative

21.4%

Avg Neutral

56.6%

News Feed

Aptinyx to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Business Wire·8/31/2021·↑ positive

Aptinyx Inc. (APTX) CEO Norbert Riedel on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/10/2021·↓ negative

Aptinyx: CNS Drug Discoverer With Depressed Price

Seeking Alpha·7/21/2021·↓ negative

Aptinyx to Participate in William Blair Biotech Focus Conference 2021

Business Wire·7/12/2021·↑ positive

Aptinyx Stock Looks Promising If You're Willing to Be Patient

InvestorPlace·7/12/2021·↑ positive

Aptinyx Provides Updates On Mid-Stage NYX-783 Program In PTSD Patients

Benzinga·6/16/2021·↑ positive

APTX Stock Price Falls Over 10% Pre-Market: Why It Happened

Pulse2·6/16/2021·↓ negative

Aptinyx Provides Update on NYX-783 Development Program for the Treatment of Post-Traumatic Stress Disorder

Business Wire·6/15/2021·↑ positive

Aptinyx Inc. (APTX) CEO Norbert Riedel on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/13/2021·↓ negative

Aptinyx Stock Price Increased Over 4% Pre-Market: Why It Happened

Pulse2·4/6/2021·↑ positive